A major breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently disabled in many kinds of malignancies, causing https://friendlybookmark.com/story21821037/nanobodies-reactivate-tumor-suppressor-p53-the-potential-approach-for-cancer-treatment